T. Rowe Price Associates »

Rigel Pharmaceuticals shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-06-30 $93k 11k 8.23

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Unitedhealth Group Comm Stk (UNH)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Netflix Comm Stk (NFLX)
Intuitive Surgical Comm Stk (ISRG)
Elevance Health Comm Stk (ELV)
Schwab Charles Corp Comm Stk (SCHW)

View all positions for T. Rowe Price Associates

Top funds holding Rigel Pharmaceuticals

Armistice Capital
BlackRock
Morgan Stanley
Soleus Capital Management
Vanguard Group
Susquehanna International
Acadian Asset Management
Assenagon Asset Management
Geode Capital Management
State Street Corporation
Stonepine Capital Management
Jacobs Levy Equity Management
Renaissance Technologies
Healthcare Of Ontario Pension Plan Trust Fund
Ing Investment Management

View all funds holding Rigel Pharmaceuticals